Trial Search Results

A Study of an Antibiotic Implant in General Surgical Subjects at Higher Risk for Surgical Wound Infection

The purpose of this study is to determine whether the gentamicin-collagen sponge is safe and effective for preventing surgical wound infections in patients undergoing colorectal surgery.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:


Collaborator: Duke University

Stanford Investigator(s):


  • Drug: gentamicin-collagen sponge dipped in saline


Phase 3


Inclusion Criteria:

   - Scheduled to undergo nonemergent colon and/or rectal surgical procedures involving a
   laparotomy incision of at least 7 cm in length or greater. List of eligible
   procedures: Left Hemicolectomy, Transverse Colectomy, Segmental/Sleeve Left Colon
   Resection, Total Abdominal Colectomy With Ileorectal Anastomosis, Total Abdominal
   Colectomy With Ileostomy, Total Abdominal Proctocolectomy (Portion Of Specimen To Be
   Extracted Via Laparotomy), Low Anterior Resection, Sigmoid Resection, Non-Emergent
   Hartmann's Procedure, Colotomy With Polypectomy Distal To Hepatic Flexure, Colostomy
   Takedown Through Laparotomy (Not Peristomal) Incision, Ileo-Pouch Anal Anastomosis,
   Abdominal Perineal Resection of the Rectum

   - Have the capacity to understand and sign an informed consent form.

   - Are male or female and > 18 years of age.

   - If female, be postmenopausal (no menstrual period for a minimum of 1 year), or
   surgically sterilized (does not have a uterus or has had bilateral tubal ligation).
   Females of child-bearing potential must have a negative serum pregnancy test on entry
   in the study, and agree to use adequate birth control during the study and for 60 days
   after the administration of study agent.

   - Agree to be available for evaluation from baseline until final evaluation at 60 days

Exclusion Criteria:

   - Known history of hypersensitivity to gentamicin or bovine collagen.

   - Undergoing emergency surgery (urgent surgery is allowed if informed consent is
   obtained and the study procedures can be performed). Emergency surgery includes cases
   where standard bowel preparation and other preoperative assessments cannot be done.

   - Undergoing a significant concomitant surgical procedure (e.g., hysterectomy). The
   following concomitant procedures are allowed: appendectomy, cholecystectomy,
   oophorectomy, liver biopsy/wedge resection (but not liver resection).

   - Undergoing a laparoscopic, laparoscopic-assisted, or other minimally invasive surgical
   approach involving a laparotomy incision less than 7 cm.

   - History of prior laparotomy within the last 60 days of this planned procedure.

   - Planned to undergo a second laparotomy or colorectal surgical procedure (e.g.
   colostomy or ileostomy takedown) within 60 days of this planned first procedure.

   - Evidence preoperatively of any of the following: sepsis, severe sepsis, or septic
   shock (note that SIRS alone is not an exclusion criterion)

   - Current abdominal wall infection/surgical site infection from previous
   laparotomy/laparoscopy or for any reason.

   - Receiving antibiotic therapy within the 1 week prior to the date of surgery.

   - Preoperative evaluation suggests intra-abdominal process that might preclude full
   closure of the skin.

   - History of ongoing treatment (e.g. chemotherapy, radiation) for non-colorectal cancer.

   - Recent history of significant drug or alcohol abuse.

   - Preoperative prothrombin time (PT) > 1.5 times upper limit of normal

   - Pregnant, lactating, or of childbearing potential not practicing a birth control
   method with a high degree of reliability

   - Postsurgical life expectancy ≤ 60 days, in the investigator's or sponsor's opinion.

   - Refusal to accept medically indicated blood products.

   - Previous participation in this or any other active Innocoll Gentamicin-Collagen Sponge

   - Participation within 30 days before the start of this study in any experimental drug
   or device study, or currently participating in a study in which the administration of
   investigational drug or device within 60 days is anticipated.

   - Surgeon does not believe that it will be possible to insert 2 sponges above the fascia
   in the patient (e.g. in a very thin patient planned to have a small incision)

   - Patients with anterior abdominal wall mesh that is not planned to be completely
   removed during the planned procedure.

   - Presence of prosthetic cardiac valve.

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Moe Jalali
Not Recruiting